Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer. | Neoplasia | 2026 | 42217442 | PubTator, text mining | PubMed |
| Uterine Myxoid Inflammatory Myofibroblastic Sarcoma (MIMS) Harboring Pathogenic KRAS Mutations and Expressing ER, PR, and CD10. | Int J Gynecol Pathol | 2026 | 42206731 | PubTator, text mining | PubMed |
| LATS kinase activity and tumor suppressor function are regulated by a second autophosphorylation site. | J Biol Chem | 2026 | 42167578 | PubTator, text mining | PubMed |
| Mitogen-activated Protein Kinase big Mitogen-activated Kinase-1 Mediates Protection in Liver Ischemia/Reperfusion Injury. | Transplantation | 2026 | 42165264 | PubTator, text mining | PubMed |
| CAF-derived exosomes drive trastuzumab resistance in HER2-positive breast cancer via YAP-USP8-HER2 axis activation. | Breast Cancer Res | 2026 | 42141445 | PubTator, text mining | PubMed |
| Potential therapeutic targets for multisite chronic pain: A proteome-wide Mendelian randomization study. | Medicine (Baltimore) | 2026 | 42116291 | PubTator, text mining | PubMed |
| EGFR-19del nuclear translocation increases HDAC7 expression inhibiting the Hippo pathway and exacerbating TKI resistance in lung adenocarcinoma. | Theranostics | 2026 | 42094614 | PubTator, text mining | PubMed |
| Phosphoproteomic and kinase networks reveal partial EMT and stress-adaptive growth programs in pediatric Peutz-Jeghers polyps. | Pediatr Res | 2026 | 42082734 | PubTator, text mining | PubMed |
| Mechanobiology of the Hippo-YAP Signaling Network. | Cold Spring Harb Perspect Biol | 2026 | 42045074 | PubTator, text mining | PubMed |
| Cisplatin-Induced Oxidative Stress Regulates YAP to Modulate Epigenome Promoting the Survival of Osteosarcoma Cells. | Biochemistry | 2026 | 41980058 | PubTator, text mining | PubMed |
| The Regulation and Function of Hippo/YAP Pathway in Cancer. | FASEB J | 2026 | 41924992 | PubTator, text mining | PubMed |
| HPV6-associated cervical squamous cell carcinoma: a case report and literature review. | Front Oncol | 2026 | 41919255 | PubTator, text mining | PubMed |
| [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916915 | PubTator, text mining | PubMed |
| Emergence of Catalytic Activity in VRK3: Phosphoproteomic Insights into the Regulatory Network of a Former Pseudokinase. | Proteomes | 2026 | 41893729 | PubTator, text mining | PubMed |
| USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation. | EMBO Rep | 2026 | 41882191 | PubTator, text mining | PubMed |
| SiO2 dust induces the transformation of lung fibroblasts to myofibroblasts by activating the S1P-RhoA-YAP signaling pathway. | Toxicol In Vitro | 2026 | 41881086 | PubTator, text mining | PubMed |
| Molecular mechanisms of NLRP3 inflammasome activation. | Exp Mol Med | 2026 | 41876821 | PubTator, text mining | PubMed |
| The APC/C subunit APC7 promotes hepatocellular carcinoma progression by mediating ubiquitination and degradation of LATS1 to activate YAP/TAZ. | Biol Direct | 2026 | 41866505 | PubTator, text mining | PubMed |
| RNF2 facilitates the progression of cervical cancer through the degradation of LATS1. | Life Sci | 2026 | 41865869 | PubTator, text mining | PubMed |
| CircBARD1 suppresses tumor progression driven by H3K18 lactylation-CCNA2 axis in human bladder cancer. | Cell Oncol (Dordr) | 2026 | 41854933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=2